SC
MIST icon

Stephenson & Company’s Milestone Pharmaceuticals MIST Stock Holding History

Stephenson & Company’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.8K Hold
20,000
– – 0.01% 43
2025
Q4 		$40.4K Hold
20,000
– – 0.02% 45
2025
Q3 		$40K Buy
+20,000
New +$35.2K 0.02% 43

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Stephenson & Company's MIST Position: Q1 2026 in Review

Stephenson & Company held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 20,000 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #43.

Stephenson & Company first reported a position in MIST in Q3 2025 and has held it in 3 quarters since. The position peaked at $40.4K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Stephenson & Company held 20,000 shares of Milestone Pharmaceuticals worth $23.8K as of Q1 2026.
  • Stephenson & Company left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
  • Milestone Pharmaceuticals made up 0.01% of Stephenson & Company's portfolio in Q1 2026, its #43 holding.
  • Stephenson & Company first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Stephenson & Company's Milestone Pharmaceuticals position peaked at $40.4K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Stephenson & Company's 13F filing for Q1 2026, filed 12 May 2026.